1- Organization,
W.H.,
International Agency For Research on Cancer GLOBOCAN 2012: estimated cancer incidence,
mortality and prevalence worldwide in 2012.
2013.
2- hoi,
S.,
et al.,
Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. The British journal of radiology,
2014.
3- Shen,
J.,
et al.,
Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer,
2004.
101(6): p.
1330-7.
4- Kutomi,
G.,
et al.,
Current status of the prognostic molecular biomarkers in breast cancer: A systematic review. Oncol Lett,
2017.
13(3): p.
1491-1498.
5- Brouckaert,
O.,
et al.,
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Ann Oncol,
2013.
24(1): p.
47-53.
6- Howell,
A.,
et al.,
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet,
1984.
1(8377): p.
588-91.
7- Beran,
L.,
et al.,
Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast. The American journal of surgery,
2005.
190(4): p.
592-594.
8- Rahbar,
H.
and S.C.
Partridge,
Multiparametric MR Imaging of Breast Cancer. Magn Reson Imaging Clin N Am,
2016.
24(1): p.
223-38.
9- Folkman,
J.,
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst,
1990.
82(1): p.
4-6.
10- Montemurro,
F.,
et al.,
Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer. European radiology,
2007.
17(6): p.
1490-1497.
11- Teifke,
A.,
et al.,
Dynamic MR imaging of breast lesions: Correlation with microvessel distribution pattern and histologic characteristics of prognosis 1. Radiology,
2006.
239(2): p.
351-360.